Histopathological Changes Associated With Dextranomer/Hyaluronic Acid Injection for Pediatric Vesicoureteral Reflux

Journal of Urology

Volumn 178, Issue 4 SUPPLEMENT, 2007, Pages 1707-1710

  Routh, Jonathan C ^a   Ashley, Richard A ^a   Sebo, Thomas J ^a   Vandersteen, David R ^b   Slezak, Jeffrey ^a   Reinberg, Yuri ^b  

^a MAYO CLINIC   (United States)

^b Pediatric Surgical Associates   (United States)

Author keywords

fibrosis; hyaluronic acid; inflammation; ureter; vesico ureteral reflux

Indexed keywords

DEXTRANOMER; HYALURONIC ACID;

ARTICLE; BLADDER; CHILD; CLINICAL ARTICLE; ENDOSCOPIC SURGERY; ENDOSCOPIC THERAPY; EXCISION; FEMALE; FIBROSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; INFLAMMATION; INJECTION SITE; MALE; PRIORITY JOURNAL; TREATMENT FAILURE; URETER; URETERONEOCYSTOSTOMY; VESICOURETERAL REFLUX;

EID: 34548434738     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2007.03.165     Document Type: Article

References (16)

1. Elder J.S., Peters C.A., Arant Jr. B.S., Ewalt D.H., Hawtrey C.E., Hurwitz R.S., et al. Pediatric Vesicoureteral Reflux Guidelines Panel summary report on the management of primary vesicoureteral reflux in children. J Urol 157 (1997) 1846
2. Puri P., Pirker M., Mohanan N., Dawrant M., Dass L., and Colhoun E. Subureteral dextranomer/hyaluronic acid injection as first line treatment in the management of high grade vesicoureteral reflux. J Urol 176 (2006) 1856
3. Stenberg A., Hensle T.W., and Lackgren G. Vesicoureteral reflux: a new treatment algorithm. Cur Urol Rep 3 (2002) 107
4. Kirsch A.J., Perez-Brayfield M., Smith E.A., and Scherz H.C. The modified sting procedure to correct vesicoureteral reflux: improved results with submucosal implantation within the intramural ureter. J Urol 171 (2004) 2413
5. Lackgren G., Wahlin N., Skoldenberg E., and Stenberg A. Long-term followup of children treated with dextranomer/hyaluronic acid copolymer for vesicoureteral reflux. J Urol 166 (2001) 1887
6. Kirsch A.J., Perez-Brayfield M.R., and Scherz H.C. Minimally invasive treatment of vesicoureteral reflux with endoscopic injection of dextranomer/hyaluronic acid copolymer: the Children's Hospitals of Atlanta experience. J Urol 170 (2003) 211
7. Routh J.C., Vandersteen D.R., Pfefferle H., Wolpert J.J., and Reinberg Y. Single center experience with endoscopic management of vesicoureteral reflux in children. J Urol 175 (2006) 1889
8. Bedir S., Kilciler M., Ozgok Y., Deveci G., and Erduran D. Long-term complication due to dextranomer based implant: granuloma causing urinary obstruction. J Urol 172 (2004) 247
9. Snodgrass W.T. Obstruction of a dysmorphic ureter following dextranomer/hyaluronic acid copolymer. J Urol 171 (2004) 395
10. Stenberg A., Larsson E., Lindholm A., Ronneus B., and Lackgren G. Injectable dextranomer-based implant: histopathology, volume changes and DNA-analysis. Scand J Urol Nephrol 33 (1999) 355
11. Stenberg A., Larsson E., and Lackgren G. Endoscopic treatment with dextranomer-hyaluronic acid for vesicoureteral reflux: histological findings. J Urol 169 (2003) 1109
12. Stenberg A., and Lackgren G. A new bioimplant for the endoscopic treatment of vesicoureteral reflux: experimental and short-term clinical results. J Urol 154 (1995) 800
13. Hoyert D.L., Kung H.C., and Smith B.L. Deaths: Preliminary Data for 2003 (2005), Centers for Disease Control, Atlanta 1-48 15
14. Routh J.C., Vandersteen D.R., Pfefferle H., Wolpert J.J., and Reinberg Y. Single center experience with endoscopic management of vesicoureteral reflux in children. J Urol 175 (2006) 1889
15. Dewan P.A. Is injected polytetrafluoroethylene (polytef) carcinogenic?. Br J Urol 69 (1992) 29
16. Balkwill F., and Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 357 (2001) 539